Researcher.Life Logo

Journal of Virus Eradication : Impact Factor & More

eISSN: 2055-6659pISSN: 2055-6640
JournalOpen Access

Key Metrics

CiteScore
5.1
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q4Virology
SNIP
1.06
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Virus Eradication

Journal of Virus Eradication Journal Specifications

Overview
Publisher MEDISCRIPT LTD
Language English
Frequency Quarterly
Article Processing ChargesUSD 2260
Publication Time39
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2015
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 39
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Journal of Virus Eradication ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Virus Eradication

Population immunity to the three serotypes of poliovirus post-interruption of wild poliovirus transmission in Nigeria
  • 29 Oct 2025
  • Journal of Virus Eradication
The impact of acute stress on the HIV reservoir: a prospective interventional trial
  • 10 Oct 2025
  • Journal of Virus Eradication
A liberalized approach to directly observed therapy for HCV retains excellent cure rates among PWID in Vienna
  • 2 Oct 2025
  • Journal of Virus Eradication
Navigating the HIV/AIDS Epidemic in Bangladesh: A Comprehensive Retrospective Analysis of Epidemiological Trends and Sex-Specific Disparities (1990–2021) with Long-Term ARIMA Forecasting to 2050 for Strategic Public Health Planning
  • 1 Oct 2025
  • Journal of Virus Eradication
2-Deoxyglucose as a therapeutic strategy for EBV-associated gastric carcinoma: Glycolytic and lytic reactivation inhibition under hypoxic conditions
  • 27 Sep 2025
  • Journal of Virus Eradication
Evolution of split-protein technologies in virology: From mechanistic discovery and diagnostics to therapeutic promise
  • 23 Sep 2025
  • Journal of Virus Eradication
Population immunity to the three serotypes of poliovirus post-interruption of wild poliovirus transmission in Nigeria
  • 29 Oct 2025
  • Journal of Virus Eradication
The impact of acute stress on the HIV reservoir: a prospective interventional trial
  • 10 Oct 2025
  • Journal of Virus Eradication
A liberalized approach to directly observed therapy for HCV retains excellent cure rates among PWID in Vienna
  • 2 Oct 2025
  • Journal of Virus Eradication
Navigating the HIV/AIDS Epidemic in Bangladesh: A Comprehensive Retrospective Analysis of Epidemiological Trends and Sex-Specific Disparities (1990–2021) with Long-Term ARIMA Forecasting to 2050 for Strategic Public Health Planning
  • 1 Oct 2025
  • Journal of Virus Eradication
2-Deoxyglucose as a therapeutic strategy for EBV-associated gastric carcinoma: Glycolytic and lytic reactivation inhibition under hypoxic conditions
  • 27 Sep 2025
  • Journal of Virus Eradication
Evolution of split-protein technologies in virology: From mechanistic discovery and diagnostics to therapeutic promise
  • 23 Sep 2025
  • Journal of Virus Eradication

FAQs on Journal of Virus Eradication